| Literature DB >> 27998721 |
Heather M Snyder1, Tim Ahles2, Stuart Calderwood3, Maria C Carrillo4, Honglei Chen5, Chung-Chou H Chang6, Suzanne Craft7, Philip De Jager8, Jane A Driver9, Howard Fillit10, David Knopman11, Michael Lotze12, Mary C Tierney13, Suzana Petanceska14, Andrew Saykin15, Sudha Seshadri16, Diana Shineman10, Mary Ganguli17.
Abstract
Recent population studies suggest an intriguing inverse relationship between several types of cancer and neurodegenerative diseases, including Alzheimer's disease. Understanding the intersection of the underlying biology for these two distinct families of diseases with one another may offer novel approaches to identify new therapeutic approaches and possible opportunities to repurpose existing drug candidates. The Alzheimer's Association and the Alzheimer's Drug Discovery Foundation convened a one-day workshop to delve into this discussion. Workshop participants outlined research focus areas, potential collaborations, and partnerships for future action.Entities:
Keywords: Alzheimer's disease; Biological mechanisms; Cancer; Epidemiology; Genetics; Oncology; Repurpose therapy
Mesh:
Substances:
Year: 2016 PMID: 27998721 PMCID: PMC5548424 DOI: 10.1016/j.jalz.2016.11.002
Source DB: PubMed Journal: Alzheimers Dement ISSN: 1552-5260 Impact factor: 21.566